LRRK2 and Parkinson disease: 18F-dopa PET has, however, detected subclinical disease in other series of asymptomatic adult LRRK2 [47], GBA [33], and heterozygous parkin mutation carriers [48], relatives of cases with known familial PD [49], and identical cotwins of PD patients [50].